Immunomodulators Market Size, Share, Trends & COVID-19 Impact Analysis, By Product Type (Immunosuppressant, Immunostimulants), By Application (Oncology, Respiratory, Multiple Sclerosis, and Others), and Regional Forecast, 2026-2034

Last Updated: April 20, 2026 | Format: PDF | Report ID: FBI104692

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Key Disease Conditions –Key Regions/Country
2. New Product Launch
3. Pipeline Analysis
4. Impact of COVID-19 on the Immunomodulators Market
5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
Global Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Geography
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. Canada
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Europe Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. Germany
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. France
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  4. Spain
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  5. Italy
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  6. Scandinavia
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  7. Rest of Europe
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Asia Pacific Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. China
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. India
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  4. Australia
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  5. Southeast Asia
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  6. Rest of Asia Pacific
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Latin America Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. Mexico
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. Rest of Latin America
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Middle East & Africa Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. South Africa
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. Rest of Middle East & Africa
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Company Profiles (Overview, Product Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. F. Hoffmann-La Roche Ltd
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Novartis AG
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. Biogen
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Teva Pharmaceutical Industries Ltd.
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. Amgen, Inc
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. Bristol-Myers & Squibb Company
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Merck Sharp & Dohme Corp.
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Eli Lilly and Company
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. Other Prominent Players
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
Strategic Recommendations

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Key Disease Conditions –Key Regions/Country
2. New Product Launch
3. Pipeline Analysis
4. Impact of COVID-19 on the Immunomodulators Market
5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
Global Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Geography
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. Canada
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Europe Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. Germany
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. France
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  4. Spain
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  5. Italy
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  6. Scandinavia
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  7. Rest of Europe
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Asia Pacific Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. China
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. India
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  4. Australia
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  5. Southeast Asia
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  6. Rest of Asia Pacific
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Latin America Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. Mexico
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. Rest of Latin America
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Middle East & Africa Immunomodulators Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Immunosuppressants
  2. Immunostimulants
3. Market Analysis, Insights and Forecast – By Application
  1. Respiratory
  2. Oncology
  3. Multiple Sclerosis
  4. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  2. South Africa
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
  3. Rest of Middle East & Africa
    1. By Product Type
      1. Immunosuppressants
      2. Immunostimulants
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Company Profiles (Overview, Product Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. F. Hoffmann-La Roche Ltd
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Novartis AG
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. Biogen
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Teva Pharmaceutical Industries Ltd.
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. Amgen, Inc
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. Bristol-Myers & Squibb Company
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Merck Sharp & Dohme Corp.
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Eli Lilly and Company
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. Other Prominent Players
    1. Overview,
    2. Product Types & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
Strategic Recommendations

Read Less

List of Figures

Figure 01: Global Immunomodulators Market Value Share (%), by Region, 2025 & 2034

Figure 02: Global Immunomodulators Market Value Share (%), By Product Type, 2025 & 2034

Figure 03: Global Immunomodulators Market Forecast (USD billion), By Immunosuppressants, 2025 -2034

Figure 04: Global Immunomodulators Market Forecast (USD billion), By Immunostimulants, 2025 -2034

Figure 05: Global Immunomodulators Market Value Share (%), By Application, 2025 & 2034

Figure 06: Global Immunomodulators Market Forecast (USD billion), By Respiratory, 2025 -2034

Figure 07: Global Immunomodulators Market Forecast (USD billion), By Oncology, 2025 -2034

Figure 08: Global Immunomodulators Market Forecast (USD billion), By Multiple Sclerosis, 2025 -2034

Figure 09: Global Immunomodulators Market Forecast (USD billion), By Others, 2025 -2034

Figure 10: North America Immunomodulators Market Value (USD billion), By Country, 2025 & 2034

Figure 11: North America Immunomodulators Market Value Share (%), By Country, 2025

Figure 12: North America Immunomodulators Market Value (USD billion), By Product Type, 2025 & 2034

Figure 13: North America Immunomodulators Market Value Share (%), By Product Type, 2025

Figure 14: North America Immunomodulators Market Value (USD billion), By Application, 2025 & 2034

Figure 15: North America Immunomodulators Market Value Share (%), By Application, 2025

Figure 16: Europe Immunomodulators Market Value (USD billion), By Country, 2025 & 2034

Figure 17: Europe Immunomodulators Market Value Share (%), By Country, 2025

Figure 18: Europe Immunomodulators Market Value (USD billion), By Product Type, 2025 & 2034

Figure 19: Europe Immunomodulators Market Value Share (%), By Product Type, 2025

Figure 20: Europe Immunomodulators Market Value (USD billion), By Application, 2025 & 2034

Figure 21: Europe Immunomodulators Market Value Share (%), By Application, 2025

Figure 22: Asia Pacific Immunomodulators Market Value (USD billion), By Country, 2025 & 2034

Figure 23: Asia Pacific Immunomodulators Market Value Share (%), By Country, 2025

Figure 24: Asia Pacific Immunomodulators Market Value (USD billion), By Product Type, 2025 & 2034

Figure 25: Asia Pacific Immunomodulators Market Value Share (%), By Product Type, 2025

Figure 26: Asia Pacific Immunomodulators Market Value (USD billion), By Application, 2025 & 2034

Figure 27: Asia Pacific Immunomodulators Market Value Share (%), By Application, 2025

Figure 28: Latin America Immunomodulators Market Value (USD billion), By Country, 2025 & 2034

Figure 29: Latin America Immunomodulators Market Value Share (%), By Country, 2025

Figure 30: Latin America Immunomodulators Market Value (USD billion), By Product Type, 2025 & 2034

Figure 31: Latin America Immunomodulators Market Value Share (%), By Product Type, 2025

Figure 32: Latin America Immunomodulators Market Value (USD billion), By Application, 2025 & 2034

Figure 33: Latin America Immunomodulators Market Value Share (%), By Application, 2025

Figure 34: Middle East & Africa Immunomodulators Market Value (USD billion), By Country, 2025 & 2034

Figure 35: Middle East & Africa Immunomodulators Market Value Share (%), By Country, 2025

Figure 36: Middle East & Africa Immunomodulators Market Value (USD billion), By Product Type, 2025 & 2034

Figure 37: Middle East & Africa Immunomodulators Market Value Share (%), By Product Type, 2025

Figure 38: Middle East & Africa Immunomodulators Market Value (USD billion), By Application, 2025 & 2034

Figure 39: Middle East & Africa Immunomodulators Market Value Share (%), By Application, 2025

Figure 40: Global Immunomodulators Market Revenue (%) Share Analysis by Key Players, 2025

List of Tables

Table 1: Global Immunomodulators Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 2: Global Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 3: Global Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 4: North America Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2021–2034

Table 5: North America Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 6: North America Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 7: Europe Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2021–2034

Table 8: Europe Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 9: Europe Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 10: Asia Pacific Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2021–2034

Table 11: Asia Pacific Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 12: Asia Pacific Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 13: Latin America Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2021–2034

Table 14: Latin America Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 15: Latin America Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 16: Middle East & Africa Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2021–2034

Table 17: Middle East & Africa Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 18: Middle East & Africa Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 120

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com